A citation-based method for searching scientific literature

Bénédicte Neven, Aude Magerus-Chatinet, Benoit Florkin, Delphine Gobert, Olivier Lambotte, Lien De Somer, Nina Lanzarotti, Marie-Claude Stolzenberg, Brigitte Bader-Meunier, Nathalie Aladjidi, Christophe Chantrain, Yves Bertrand, Eric Jeziorski, Guy Leverger, Gérard Michel, Felipe Suarez, Eric Oksenhendler, Olivier Hermine, Stéphane Blanche, Capucine Picard, Alain Fischer, Frédéric Rieux-Laucat. Blood 2011
Times Cited: 87







List of co-cited articles
750 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
254
58

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
39

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Aude Magerus-Chatinet, Bénédicte Neven, Marie-Claude Stolzenberg, Cécile Daussy, Peter D Arkwright, Nina Lanzarotti, Catherine Schaffner, Sophie Cluet-Dennetiere, Filomeen Haerynck, Gérard Michel,[...]. J Clin Invest 2011
78
41

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
192
34

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Kennichi C Dowdell, Julie E Niemela, Susan Price, Joie Davis, Ronald L Hornung, João Bosco Oliveira, Jennifer M Puck, Elaine S Jaffe, Stefania Pittaluga, Jeffrey I Cohen,[...]. Blood 2010
75
38

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
Susan Price, Pamela A Shaw, Amy Seitz, Gyan Joshi, Joie Davis, Julie E Niemela, Katie Perkins, Ronald L Hornung, Les Folio, Philip S Rosenberg,[...]. Blood 2014
125
33

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
32

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
304
31

How I treat autoimmune lymphoproliferative syndrome.
V Koneti Rao, João Bosco Oliveira. Blood 2011
86
29

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
95
24

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
Iusta Caminha, Thomas A Fleisher, Ronald L Hornung, Janet K Dale, Julie E Niemela, Susan Price, Joie Davis, Katie Perkins, Kennichi C Dowdell, Margaret R Brown,[...]. J Allergy Clin Immunol 2010
56
35

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
464
22

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
19

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal,[...]. Blood 2006
78
21

Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations.
Joshua D Milner, Tiphanie P Vogel, Lisa Forbes, Chi A Ma, Asbjørg Stray-Pedersen, Julie E Niemela, Jonathan J Lyons, Karin R Engelhardt, Yu Zhang, Nermina Topcagic,[...]. Blood 2015
300
19

Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
Desirée Schubert, Claudia Bode, Rupert Kenefeck, Tie Zheng Hou, James B Wing, Alan Kennedy, Alla Bulashevska, Britt-Sabina Petersen, Alejandro A Schäffer, Björn A Grüning,[...]. Nat Med 2014
486
19

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
148
18

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
495
18

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
David T Teachey, Robert Greiner, Alix Seif, Edward Attiyeh, Jack Bleesing, John Choi, Catherine Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen,[...]. Br J Haematol 2009
106
18

Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.
Hye Sun Kuehn, Weiming Ouyang, Bernice Lo, Elissa K Deenick, Julie E Niemela, Danielle T Avery, Jean-Nicolas Schickel, Dat Q Tran, Jennifer Stoddard, Yu Zhang,[...]. Science 2014
511
18

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
17

FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Hye Sun Kuehn, Iusta Caminha, Julie E Niemela, V Koneti Rao, Joie Davis, Thomas A Fleisher, João B Oliveira. J Immunol 2011
38
39

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Faith Dugan, Janet K Dale, Joie Davis, Jean Tretler, John K Hurley, Thomas Fleisher, Jennifer Puck, Stephen E Straus. Br J Haematol 2005
76
19

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
231
17

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.
Julie E Niemela, Lianghao Lu, Thomas A Fleisher, Joie Davis, Iusta Caminha, Marc Natter, Laurel A Beer, Kennichi C Dowdell, Stefania Pittaluga, Mark Raffeld,[...]. Blood 2011
86
16

Chronic lymphadenopathy simulating malignant lymphoma.
V C Canale, C H Smith. J Pediatr 1967
145
16


AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
Bernice Lo, Kejian Zhang, Wei Lu, Lixin Zheng, Qian Zhang, Chrysi Kanellopoulou, Yu Zhang, Zhiduo Liu, Jill M Fritz, Rebecca Marsh,[...]. Science 2015
346
16

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
Masatoshi Takagi, Kunihiro Shinoda, Jinhua Piao, Noriko Mitsuiki, Mari Takagi, Kazuyuki Matsuda, Hideki Muramatsu, Sayoko Doisaki, Masayuki Nagasawa, Tomohiro Morio,[...]. Blood 2011
84
15

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Catherine S Manno, Kelly M Axsom, Timothy Andrews, John K Choi, Barbara H Greenbaum, Joseph M McMann, Kathleen E Sullivan, Susan F Travis, Stephan A Grupp. Blood 2005
103
14

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
14

Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
Shigui Zhu, Amy P Hsu, Marla M Vacek, Lixin Zheng, Alejandro A Schäffer, Janet K Dale, Joie Davis, Roxanne E Fischer, Stephen E Straus, Donna Boruchov,[...]. Hum Genet 2006
43
30

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Karen L Bride, Tiffaney Vincent, Kim Smith-Whitley, Michele P Lambert, Jack J Bleesing, Alix E Seif, Catherine S Manno, James Casper, Stephan A Grupp, David T Teachey. Blood 2016
109
14

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
V Koneti Rao, Susan Price, Katie Perkins, Patricia Aldridge, Jean Tretler, Joie Davis, Janet K Dale, Fred Gill, Kip R Hartman, Linda C Stork,[...]. Pediatr Blood Cancer 2009
57
21

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
116
13

Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
Anne Rensing-Ehl, Simon Völkl, Carsten Speckmann, Myriam Ricarda Lorenz, Julia Ritter, Ales Janda, Mario Abinun, Hanspeter Pircher, Bertram Bengsch, Robert Thimme,[...]. Blood 2014
31
38

Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.
Amy P Hsu, Kennichi C Dowdell, Joie Davis, Julie E Niemela, Stacie M Anderson, Pamela A Shaw, V Koneti Rao, Jennifer M Puck. Genet Med 2012
21
52

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
12

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Lilia L Bi, George Pan, T Prescott Atkinson, Lixin Zheng, Janet K Dale, Christopher Makris, Vishnu Reddy, Jay M McDonald, Richard M Siegel, Jennifer M Puck,[...]. BMC Med Genet 2007
49
22

Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Nina Lanzarotti, Bénédicte Neven, Cécile Daussy, Capucine Picard, Nathalie Neveux, Mukesh Desai, Meghana Rao, Kanjaksha Ghosh,[...]. J Allergy Clin Immunol 2013
28
39

Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients.
Bénédicte Neven, Julie Bruneau, Marie-Claude Stolzenberg, Isabelle Meyts, Aude Magerus-Chatinet, Leen Moens, Nina Lanzarotti, Sandra Weller, Denise Amiranoff, Benoit Florkin,[...]. Blood 2014
23
47

Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.
Carrie L Lucas, Hye Sun Kuehn, Fang Zhao, Julie E Niemela, Elissa K Deenick, Umaimainthan Palendira, Danielle T Avery, Leen Moens, Jennifer L Cannons, Matthew Biancalana,[...]. Nat Immunol 2014
388
12

Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.
Sarah E Flanagan, Emma Haapaniemi, Mark A Russell, Richard Caswell, Hana Lango Allen, Elisa De Franco, Timothy J McDonald, Hanna Rajala, Anita Ramelius, John Barton,[...]. Nat Genet 2014
303
12

Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.
Christian Klemann, Myrian Esquivel, Aude Magerus-Chatinet, Myriam R Lorenz, Ilka Fuchs, Nathalie Neveux, Martin Castelle, Jan Rohr, Claudia Bettoni da Cunha, Martin Ebinger,[...]. Haematologica 2017
24
45

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
M van der Burg, R de Groot, W M Comans-Bitter, J C den Hollander, H Hooijkaas, H J Neijens, R M Berger, A P Oranje, A W Langerak, J J van Dongen. Pediatr Res 2000
41
24

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Dana A Obzut, Kelly Axsom, John K Choi, Kelly C Goldsmith, Junior Hall, Jessica Hulitt, Catherine S Manno, John M Maris, Nicholas Rhodin,[...]. Blood 2006
62
14

Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency.
A Rensing-Ehl, K Warnatz, S Fuchs, M Schlesier, U Salzer, R Draeger, I Bondzio, Y Joos, A Janda, M Gomes,[...]. Clin Immunol 2010
39
23

Clinical, immunological, and pathological consequences of Fas-deficient conditions.
F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
151
10

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
145
10

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R M Siegel, J K Frederiksen, D A Zacharias, F K Chan, M Johnson, D Lynch, R Y Tsien, M J Lenardo. Science 2000
497
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.